Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Worthington Enterprises
WOR
$2.85B
| $10.1M | 0.02% |
389,604
-361,382
| -48% | -$8.97M |
|
802
Marriott Vacations Worldwide
VAC
$4.17B
| $10.1M | 0.02% |
191,200
+144,500
| +309% | +$7.26M |
|
803
WaFd
WAFD
$2.81B
| $10.1M | 0.02% |
432,276
-44,700
| -9% | -$1.02M |
|
|
PTP
804
DELISTED
PLATINUM UNDERWRITERS HLDGS LTD
PTP
| $10.1M | 0.02% |
164,000
+37,200
| +29% | +$2.28M |
|
805
Teleflex
TFX
$5.82B
| $10M | 0.02% |
+106,800
| New | +$9.79M |
|
|
AJRD
806
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $10M | 0.02% |
555,195
-164,300
| -23% | -$2.8M |
|
|
NTL
807
DELISTED
Nortel Invesora 1/20 Ser B Shr
NTL
| $10M | 0.02% |
502,700
+3,200
| +0.6% | +$69K |
|
|
TESS
808
DELISTED
Tessco Technologies Inc
TESS
| $9.95M | 0.02% |
246,700
-10,990
| -4% | -$411K |
|
809
Gentex
GNTX
$4.99B
| $9.92M | 0.02% |
601,596
-888,200
| -60% | -$13M |
|
810
Mesa Laboratories
MLAB
$633M
| $9.92M | 0.02% |
126,188
+14,988
| +13% | +$1.09M |
|
811
Gold Fields
GFI
$35.4B
| $9.88M | 0.02% |
3,088,000
+749,905
| +32% | +$3.07M |
|
|
DRIV
812
DELISTED
DIGITAL RIVER INC.
DRIV
| $9.85M | 0.02% |
533,466
-292,500
| -35% | -$5.23M |
|
813
Future Fuel
FF
$249M
| $9.72M | 0.02% |
615,300
+159,800
| +35% | +$2.69M |
|
|
PDCO
814
DELISTED
Patterson Companies, Inc.
PDCO
| $9.71M | 0.02% |
235,804
-486,600
| -67% | -$20.2M |
|
|
TAYC
815
DELISTED
TAYLOR CAPITAL GROUP INC
TAYC
| $9.66M | 0.02% |
363,434
+11,734
| +3% | +$280K |
|
816
Forward Air
FWRD
$682M
| $9.65M | 0.02% |
219,700
-53,539
| -20% | -$2.23M |
|
|
XOXO
817
DELISTED
Xo Group Inc
XOXO
| $9.63M | 0.02% |
648,300
+149,900
| +30% | +$2.12M |
|
|
XEC
818
DELISTED
CIMAREX ENERGY CO
XEC
| $9.61M | 0.02% |
+91,598
| New | +$9.28M |
|
|
GMK
819
DELISTED
GRUMA SAB DE C V ADS(RP 4 B SHS
GMK
| $9.59M | 0.02% |
314,500
+12,800
| +4% | +$347K |
|
820
McCormick & Company Non-Voting
MKC
$14.6B
| $9.54M | 0.02% |
276,800
+166,400
| +151% | +$5.68M |
|
|
BBBY
821
Bed Bath & Beyond
BBBY
$423M
| $9.52M | 0.02% |
411,412
-48,449
| -11% | -$981K |
|
|
ARI
822
Apollo Commercial Real Estate
ARI
$886M
| $9.51M | 0.02% |
585,400
-128,396
| -18% | -$2.08M |
|
|
EGOV
823
DELISTED
NIC Inc
EGOV
| $9.51M | 0.02% |
382,172
+11,712
| +3% | +$276K |
|
824
H&R Block
HRB
$6.76B
| $9.49M | 0.02% |
326,700
-2,300,000
| -88% | -$65.3M |
|
825
American Public Education
APEI
$828M
| $9.47M | 0.02% |
217,800
+54,347
| +33% | +$2.24M |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.